Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Plos One|January 28, 2014
9β Polymorphism of the glucocorticoid receptor gene appears to have limited impact in patients with Addison's diseaseIan Louis Ross, Collet Dandara, Marelize Swart, et al.
Frontiers in Genetics|January 19, 2016
An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS PatientsMarelize Swart, Jonathan Evans, Michelle Skelton, et al.
Omics : a Journal of Integrative Biology|March 8, 2014
How does mother-to-child transmission of HIV differ among African populations? Lessons from MBL2 genetic variation in ZimbabweansKudakwashe Mhandire, Gavin Pharo, Gwendolene Q Kandawasvika, et al.
BMC Infectious Diseases|February 3, 2016
Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variationFrancoise Pinillos, Collet Dandara, Marelize Swart, et al.
The Journal of Molecular Diagnostics : JMD|February 23, 2019
Analytical Validation of Variants to Aid in Genotype-Guided Therapy for OncologyMarelize Swart, Wesley M Stansberry, Victoria M Pratt, et al.
Omics : a Journal of Integrative Biology|September 9, 2015
Effects of CYP2B6 and CYP1A2 Genetic Variation on Nevirapine Plasma Concentration and Pharmacodynamics as Measured by CD4 Cell Count in Zimbabwean HIV-Infected PatientsDoreen Mhandire, Miguel Lacerda, Sandra Castel, et al.
Pharmacogenetics and Genomics|November 30, 2018
Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapyKimberly S Collins, Victoria M Pratt, Wesley M Stansberry, et al.
Clinical Pharmacology and Therapeutics|September 30, 2017
Variants in the CYP2B6 3'UTR Alter In Vitro and In Vivo CYP2B6 Activity: Potential Role of MicroRNAsKimberly S Burgess, Joseph Ipe, Marelize Swart, et al.
Clinical Pharmacology and Therapeutics|April 22, 2019
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral TherapyZeruesenay Desta, Roseann S Gammal, Li Gong, et al.
Pageof 2